Johan Rutger Christenson
Chairman bij Aprea Personal AB
Oorsprong van het eerstegraads netwerk van Johan Rutger Christenson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Karolinska Institutet
32
| College/University | Other Consumer Services | 32 |
26
| Public Company | Pharmaceuticals: Major | 26 |
| Public Company | Biotechnology | 22 | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
21
| Subsidiary | Investment Managers | 21 |
Resistentia Pharmaceuticals AB
 Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Resistentia Pharmaceutical's business strategy is to develop and commercialize immunotherapy as a second generation therapy to monoclonal antibodies for the treatment of chronic diseases. Resistentia’s most advanced program is an immunotherapy against allergy/asthma – a growing health problem with a large unmet medical need. In contrast to existing therapies, which are largely symptomatic, Resistentia’s novel immunotherapeutic approach targets the cause of the allergic reactions, rather than the symptoms. In addition, Resistentia is developing an immunotherapy for the treatment of rheumatoid arthritis. The project is currently in discovery phase.
16
| Extinct | Pharmaceuticals: Major | 16 |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA.
10
| Holding Company | Biotechnology | 10 |
BeneChill, Inc.
 BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA.
7
| Subsidiary | Medical Specialties | 7 |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden.
5
| Private Company | Pharmaceuticals: Major | 5 |
Healthcap Orx Holdings Gp AB
 Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden.
4
| Private Company | Investment Banks/Brokers | 4 |
Healthcap 1999 GP AB
 Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a private company that manages and trades securities. The company is based in Stockholm, Sweden.
4
| Subsidiary | Investment Banks/Brokers | 4 |
Ancilla AB
 Ancilla AB Real Estate DevelopmentFinance Ancilla AB manages real properties. The company is headquartered in Stockholm, Sweden.
2
| Private Company | Real Estate Development | 2 |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom.
1
| Subsidiary | Drugstore Chains | 1 |
Healthcap Aero Holdings Gp
1
| Private Company | 1 | |
Aprea Personal AB
1
| Subsidiary | 1 | |
Trimb Holding AB
 Trimb Holding AB Financial ConglomeratesFinance Part of Karo Healthcare AB, Trimb Holding AB operates as a holding Swedish company with interest in pharmaceuticals. The private company is based in Stockholm, Sweden.
1
| Subsidiary | Financial Conglomerates | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Johan Rutger Christenson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact Corporate Officer/Principal | |
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Founder Founder | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Chief Executive Officer Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BIOTAGE AB | Medical Specialties | Director/Board Member Founder Chief Executive Officer Director/Board Member | |
Odlander, Fredrikson & Co. AB
 Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Founder Chairman | |
BioStratum, Inc.
 BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Yale University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| The University of Colorado | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Masters Business Admin Corporate Officer/Principal Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman President | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| University of Oslo | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Executive Officer Chief Executive Officer | |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| BONESUPPORT HOLDING AB | Medical Specialties | Chairman Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chairman Director/Board Member Founder Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
LTB4 Sweden AB
 LTB4 Sweden AB BiotechnologyHealth Technology LTB4 Sweden AB engages in research and product development related to antimicrobial and anti-inflammatory substances through its subsidiaries. The company was founded by Bengt Ingemar Samuelsson on February 26, 2004 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder Director/Board Member Chairman Chief Executive Officer | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Director/Board Member Private Equity Investor Chairman | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
NVC Holding AB
 NVC Holding AB Investment Banks/BrokersFinance NVC Holding AB owns and manages shares in companies and real property. The company is headquartered in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Chief Executive Officer Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Corporate Officer/Principal Chairman Director/Board Member | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
HealthCap Advisor AB
 HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Healthcap Annex Fund I-Ii Bis Gp AB
 Healthcap Annex Fund I-Ii Bis Gp AB Financial ConglomeratesFinance Healthcap Annex Fund I-Ii Bis Gp AB operates as an investment holding Swedish company. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
Doctrin AB
 Doctrin AB Internet Software/ServicesTechnology Services Doctrin AB offers consultancy services within healthcare sector. It offers digital solutions that enable healthcare providers to prioritize, treat, and follow-up with their patients. The company was founded by Per Eriksson, Ashkan Labaf, Magnus Liungman, and Carslo Lorente in 2016 and is headquartered in Stockholm, Sweden. | Internet Software/Services | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Tribune Therapeutics AB
 Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
Nordic Vision Clinics AS
 Nordic Vision Clinics AS Hospital/Nursing ManagementHealth Services Part of NVC Holding AB, Nordic Vision Clinics AS is a Norwegian company that provides laser eye surgery. The private company is based in Oslo, Norway. | Hospital/Nursing Management | Director/Board Member Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
| Zweden | 31 |
| Verenigde Staten | 12 |
| Noorwegen | 5 |
| Verenigd Koninkrijk | 3 |
| Frankrijk | 3 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 4 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 742 |
| Corporate Officer/Principal | 251 |
| Chairman | 160 |
| Independent Dir/Board Member | 151 |
| Chief Executive Officer | 92 |
Sterkste connecties
- Beurs
- Insiders
- Johan Rutger Christenson
- Bedrijfsconnecties
